UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Trans-ungual Delivery of AR-12, a Novel Antifungal Drug

AAPS PharmSciTech, 2017-10, Vol.18 (7), p.2702-2705

2017

Volltextzugriff (PDF)

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers

European journal of cancer (1990), 2014-11, Vol.50, p.142-142

2014

Volltextzugriff (PDF)

Some important considerations in the use of cyclodextrins

Pharmaceutical research, 1999-12, Vol.16 (12), p.1796-1798

1999

Volltextzugriff (PDF)

712TiP A phase I/II multicenter, open-label, dose-escalation, safety, pharmacodynamic, and pharmacokinetic study of Q901 administered via intravenous infusion in adult patients with selected advanced solid tumors with a cohort expansion at the recommended phase II dose

Annals of oncology, 2023-10, Vol.34, p.S492-S492

2023

Volltextzugriff (PDF)

Investigation of the Utility of an In Vitro Release Test for Optimizing Semisolid Dosage Forms

Pharmaceutical development and technology, 2001-01, Vol.6 (3), p.469-476

2001

Volltextzugriff (PDF)

Preformulation Study of Epigallocatechin Gallate, a Promising Antioxidant for Topical Skin Cancer Prevention

Journal of pharmaceutical sciences, 2002-01, Vol.91 (1), p.111-116

2002

Volltextzugriff (PDF)

A Simplified and Rapid High-Performance Liquid Chromatographic Assay for Ketoprofen in Isopropyl Myristate

Journal of chromatographic science, 1998-10, Vol.36 (10), p.495-498

1998

Volltextzugriff (PDF)

Influence of degree of substitution of cyclodextrins on their colligative properties in solution

Journal of pharmaceutical sciences, 2001-08, Vol.90 (8), p.1086-1090

2001

Volltextzugriff (PDF)

Anhydrous Carbopol® Polymer Gels for the Topical Delivery of Oxygen Water Sensitive Compounds

Pharmaceutical development and technology, 2002-01, Vol.7 (2), p.249-255

2002

Volltextzugriff (PDF)

Effect of Temperature and Light on the Stability of Latanoprost and its Clinical Relevance

Journal of glaucoma, 2001-10, Vol.10 (5), p.401-405

2001

Volltextzugriff (PDF)

Topical Formulation Studies with DEET (N,N‐Diethyl‐3‐methylbenzamide) and Cyclodextrins

Journal of pharmaceutical sciences, 2002-01, Vol.91 (1), p.101-110

2002

Volltextzugriff (PDF)

Magnetic field effects in nematic and smectic liquid crystals probed by time resolved observation of orientation relaxation of the spin probe

Physical chemistry chemical physics : PCCP, 2018, Vol.20 (27), p.18340-18347

2018

Volltextzugriff (PDF)

The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions

Scientific reports, 2017-12, Vol.7 (1), p.17565-12, Article 17565

2017

Volltextzugriff (PDF)

MANAGEMENT OF THE WORKPLACES BY THE FACILITIES OF OPERATIONS RESEARCH

Informatyka, automatyka, pomiary w gospodarce i ochronie środowiska, 2022-09, Vol.12 (3), p.69-73

2022

Volltextzugriff (PDF)

651 A phase 1, multicenter, open-label, dose-escalation, safety, pharmacodynamic, pharmacokinetic study of Q702 with a cohort expansion at the RP2D in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A742-A742

2023

Volltextzugriff (PDF)

Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes

Journal of antimicrobial chemotherapy, 2017-09, Vol.72 (9), p.2438-2442

2017

Volltextzugriff (PDF)

Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function

Oncotarget, 2016-03, Vol.7 (11), p.12975-12996

2016

Volltextzugriff (PDF)

A Brief Overview of Scientific and Publicistic Writings of Major Archbishop of the Ukrainian Greek Catholic Church Josyf Slipyi

Studia Orientalne, 2022, Vol.24 (4), p.160-171

Proniuk, Mariia

2022

Volltextzugriff (PDF)

ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN) IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi22-vi22

2019

Volltextzugriff (PDF)

Abstract 1646: Synthesis of [11C]onapristone for clinical investigation

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1646-1646

2014

Volltextzugriff (PDF)

Abstract 4636: Pharmacokinetic (PK) food effect study of immediate-release onapristone and its primary metabolite (M1) in healthy female subjects: implications for design of a new formulation

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4636-4636

2014

Volltextzugriff (PDF)

Validation of a population pharmacokinetic (PPK) model for onapristone (ONA) in patients (pts) with cancer: Analysis of 2 clinical trials

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14099-e14099

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)
Dissertationen
(1)

Sprache

Englisch
(34)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(12)
Pharmacology & Pharmacy
(9)
Biological And Medical Sciences
(7)
General Pharmacology
(7)
Medical Sciences
(7)
Pharmacology. Drug Treatments
(7)
Chemistry
(6)
Pharmaceutical Technology. Pharmaceutical Industry
(6)
Physical Sciences
(6)
Chemistry, Multidisciplinary
(4)
Chemistry, Pharmaceutical
(4)
Drug Stability
(4)
Humans
(4)
Adult
(3)
Chemistry, Medicinal
(3)
Female
(3)
Oncology
(3)
Pharmacokinetics
(3)
Administration, Topical
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trans-ungual Delivery of AR-12, a Novel Antifungal Drug

Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers

Some important considerations in the use of cyclodextrins

712TiP A phase I/II multicenter, open-label, dose-escalation, safety, pharmacodynamic, and pharmacokinetic study of Q901 administered via intravenous infusion in adult patients with selected advanced solid tumors with a cohort expansion at the recommended phase II dose

Investigation of the Utility of an In Vitro Release Test for Optimizing Semisolid Dosage Forms

Preformulation Study of Epigallocatechin Gallate, a Promising Antioxidant for Topical Skin Cancer Prevention

A Simplified and Rapid High-Performance Liquid Chromatographic Assay for Ketoprofen in Isopropyl Myristate

Influence of degree of substitution of cyclodextrins on their colligative properties in solution

Anhydrous Carbopol® Polymer Gels for the Topical Delivery of Oxygen Water Sensitive Compounds

Effect of Temperature and Light on the Stability of Latanoprost and its Clinical Relevance

Topical Formulation Studies with DEET (N,N‐Diethyl‐3‐methylbenzamide) and Cyclodextrins

Magnetic field effects in nematic and smectic liquid crystals probed by time resolved observation of orientation relaxation of the spin probe

The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

MANAGEMENT OF THE WORKPLACES BY THE FACILITIES OF OPERATIONS RESEARCH

651 A phase 1, multicenter, open-label, dose-escalation, safety, pharmacodynamic, pharmacokinetic study of Q702 with a cohort expansion at the RP2D in patients with advanced solid tumors

Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes

Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function

A Brief Overview of Scientific and Publicistic Writings of Major Archbishop of the Ukrainian Greek Catholic Church Josyf Slipyi

ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN) IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA

Abstract 1646: Synthesis of [11C]onapristone for clinical investigation

Abstract 4636: Pharmacokinetic (PK) food effect study of immediate-release onapristone and its primary metabolite (M1) in healthy female subjects: implications for design of a new formulation

Validation of a population pharmacokinetic (PPK) model for onapristone (ONA) in patients (pts) with cancer: Analysis of 2 clinical trials

Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with castration-resistant prostate cancer (CRPC) incorporating plasma DNA analysis to define androgen receptor (AR) status

Suchergebnisse filtern